Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
3.040
+0.270 (9.75%)
Mar 14, 2025, 4:00 PM EST - Market closed
Humacyte Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Mar '25 Mar 14, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 391 | 294 | 218 | 747 | 131 | - |
| Market Cap Growth | 114.24% | 35.19% | -70.86% | 471.21% | - | - |
| Enterprise Value | 450 | 251 | 97 | 549 | 39 | - |
| Last Close Price | 3.04 | 2.84 | 2.11 | 7.25 | 10.17 | - |
| PS Ratio | - | - | 139.03 | 591.27 | 87.68 | - |
| PB Ratio | -6.14 | 21.72 | 1.86 | 6.11 | 1.85 | - |
| P/TBV Ratio | - | 21.72 | 1.86 | 6.11 | - | - |
| EV/Sales Ratio | - | - | 61.82 | 434.31 | 25.88 | - |
| Debt / Equity Ratio | -1.25 | 4.29 | 0.43 | 0.42 | 0.41 | 0.21 |
| Asset Turnover | - | - | 0.01 | 0.01 | 0.01 | - |
| Quick Ratio | 0.98 | 4.36 | 7.76 | 20.42 | 3.56 | 8.70 |
| Current Ratio | 1.10 | 4.52 | 7.88 | 20.75 | 3.69 | 8.76 |
| Return on Equity (ROE) | - | -169.81% | -10.01% | -27.46% | -65.58% | - |
| Return on Assets (ROA) | -53.23% | -36.44% | -21.54% | -25.81% | -29.32% | - |
| Return on Capital (ROIC) | -128.12% | -50.64% | -31.01% | -37.20% | -31.18% | - |
| Earnings Yield | -39.08% | -37.66% | -5.50% | -3.55% | -50.88% | - |
| FCF Yield | -23.59% | -25.70% | -33.17% | -10.90% | -42.75% | - |
| Buyback Yield / Dilution | -9.01% | -0.36% | -157.82% | -593.25% | 71.34% | - |
| Total Shareholder Return | -9.01% | -0.36% | -157.82% | -593.25% | 71.34% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.